靶点- |
|
在研机构- |
|
在研适应症- |
|
最高研发阶段无进展 |
首次获批国家/地区- |
首次获批日期- |
Study on the Safety and Effectiveness of UCB-NK Cell Infusion in the Treatment of Advanced Gastric Cancer and Gastroesophageal Cancer
This study is an open, single infusion, cell infusion dose /method exploration study. In patients with gastric cancer and gastroesophageal cancer without effective treatment, the safety of UCB-NK cell immunotherapy was evaluated and the preliminary curative effect results were obtained.
100 项与 山东金砖生物科技有限公司 相关的临床结果
0 项与 山东金砖生物科技有限公司 相关的专利(医药)
100 项与 山东金砖生物科技有限公司 相关的药物交易
100 项与 山东金砖生物科技有限公司 相关的转化医学